Clinical Trials Logo

Clinical Trial Summary

Postnatal depression (PND) is a type of depression that can occur in some parents after the birth of their baby. PND has been estimated to affect 1 in 10 new parents; mothers in particular are at an increased risk of developing PND in the first year after childbirth. Symptoms of PND include a persistent feeling of sadness or low mood, a lack of enjoyment and loss of interest in the wider world, lack of energy and feeling tired all the time, difficulty bonding with your baby, withdrawing from contact with other people and problems concentrating and making decisions. Research has shown that mothers with PND have more cognitive, behavioural and interpersonal issues, and lower mood, energy and concentration than mothers without PND. Current treatments for PND include self-help resources, support from local and national organisations, psychological therapy or antidepressants with varying success rates. Further research is required to investigate accessible, cost-effective preventions or treatments for new mothers who are at risk or have been diagnosed with PND. There is also a pressing need to investigate natural alternatives to medication, especially for breastfeeding mothers who do not want to expose their infants to pharmaceuticals through breast milk. Flavonoids are naturally occurring compounds found in high levels in foods such as berry and citrus fruits, leafy green vegetables, tea, dark chocolate and red wine. Evidence suggests that consumption of high flavonoid foods can improve health and cognitive outcomes. Prior research investigating daily dietary flavonoid intervention in a postnatal population for 2 weeks indicated significantly higher physical quality of life and significantly lower state anxiety in mothers of infants under 1 year old, at the end of the intervention. These benefits were not observed in the control group. This data shows promise for the management of mood in a key period for mothers and their babies, where risk of PND is high. The research aim of the current study will be to further these investigations to see whether implementation of a high flavonoid diet across a 2 week period positively affects maternal mental health, specifically mood, anxiety, depressive symptoms and perceived quality of life. The study will involve recruiting mothers of infants under 6 months old to take part in an online study investigating diet and mental health. Mothers will be assigned to either a high flavonoid diet or a control condition for 2 weeks. They will complete online questionnaires (Positive and Negative Affect Scale (PANAS), Edinburgh Postnatal Depression Scale (EPDS), Postpartum-Specific Anxiety Scale (PSAS), World Health Organization Quality of Life (WHOQOL), State-Trait Anxiety Inventory (STAI) and Food Frequency Questionnaire (FFQ) at the start (day 0) and end (day 14) of the dietary intervention. In this study, a sub-sample of fathers will also be recruited to take part in the same study to assess if dietary or mood outcomes are similar or different in this population. This pilot data will inform future research of dietary interventions in new fathers. The study does not pose ethical issues. Participants will be asked to complete non-invasive questionnaires about their mood and quality of life. For those in the high flavonoid group the change to diet will not be extreme; this group will be encouraged to include 2 items from a list of high flavonoid foods in their daily food consumption. All participants will be provided with helplines and web links upon debrief should they wish to seek further support. The helplines provided will be Samaritans UK and PANDAs Foundation. Web links to NHS, MIND and the Association for Postnatal Illness will also be listed.


Clinical Trial Description

The study will employ a between-groups, randomised, controlled, participant-blind design. The study will primarily recruit mothers of infants under 6 months old to take part. Participants will be invited to an online study investigating diet and mental health and will be provided with an information sheet detailing what the study entails. If participants would like to take part, they will be sent a weblink to the online study. Participants will be randomly assigned to either the intervention (consumption of high flavonoid food items) or the control (no change to diet) condition. Only the experimenters will know which group participants have been assigned to to prevent participants unconsciously biasing results. The online study will be hosted on Jisc online surveys. Once participants open the study weblink, they will be presented with the study information sheet followed by a consent form. Once participants have consented to take part, they will be asked to provide some demographic information about themselves (e.g. age, occupation, health or psychological diagnoses, any pregnancy or birth complications) and their baby (e.g. age, sex, health diagnoses, breast or bottle feeding). Mothers will then complete PANAS-NOW, EPDS, PSAS, WHOQOL, STAI and FFQ measures. Once completed, they either will (if in high flavonoid group) or will not (if in control group) be presented with a high-flavonoid food list and instructions for food consumption over the 2 week intervention. Those presented with the high flavonoid food list will be encouraged to consume 2 high flavonoid food items per day from the list over the next 2 weeks, above what they already consume each day typically. Both intervention and control groups will be encouraged to fill in food logs where they will write down all food consumption every day over the 2 week period. One and a half weeks into the intervention study participants will be reminded (via email) to complete the follow up questionnaires via a weblink when convenient for them over the next few days. They will then complete the online questionnaires (PANAS-NOW, EPDS, PSAS, WHOQOL, STAI and FFQ) via the weblink at the end of the dietary intervention (day 14). Upon completion, participants will be presented with a debrief sheet explaining the aims of the study, what the study entailed and which condition they were in. Participants will also be reminded of their right to withdraw their data from the study if they wish. Helplines and support weblinks will be provided to all participants as well as encouragement for participants to contact their GP should they wish to seek support. Alongside recruitment of postnatal mothers, fathers will also be invited to take part in the study, recruited via the mothers that consent to take part. This is so that important pilot data can be collected on a sub-sample of postnatal fathers to assess mood outcomes in this at-risk population before and after a 2 week dietary flavonoid intervention. This will follow the same methods, procedures and measures as recruited mothers. The study aims to recruit 80 postnatal mothers. A power analysis using GPower 3.1 rendered a total sample size of 40 as appropriate to obtain a small effect (0.3) at a power of 0.95 and alpha level of 0.05. The recruitment aim will be 80 to allow for a number of participant dropouts and to allow sufficiently powered analysis between groups at baseline. An additional aim is to recruit a sub-sample of 20 postnatal fathers alongside the main study recruiting mothers. This is to collect important pilot data to assess whether similar or different patterns or outcomes occur in a postnatal male population to inform future research into dietary intervention in men. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04990622
Study type Interventional
Source University of Reading
Contact
Status Completed
Phase N/A
Start date June 28, 2021
Completion date February 23, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1